Taken together, our study suggests that more research is warranted on ATE risk associated with ALK-positive NSCLC, while accounting for multiple ATE risk factors to further test the hypothesis that ALK-positive NSCLC might be associated with an increased ATE risk. This evidence concerns the gene ALK and non-small cell lung carcinoma.